Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins

This publication has 17 references indexed in Scilit:

• Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: Serum protein binding of gestodene and influence of treatment on free and total testosterone levels in the serum
  Contraception, 1993
• Serum Concentrations of Ethinylestradiol, 3-Keto-Desogestrel, SHBG, CBG and Gonadotropins during Treatment with a Biphasic Oral Contraceptive Containing Desogestrel
  Hormone Research, 1992
• Comparison of two triphasic contraceptives with different progestogens: Effects on metabolism and coagulation proteins
  Contraception, 1990
• Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone
  Contraception, 1990
• Supportive European Data on a New Oral Contraceptive Containing Norgestimate
  Acta Obstetricia et Gynecologica Scandinavica, 1990
• Effect of two oral contraceptives containing 30 μg ethinylestradiol and 75 μg gestodene or 150 μg desogestrel upon various hormonal parameters
  Contraception, 1988
• Alterations in the serum levels of gestodene and SHBG during 12 cycles of treatment with 30 μg ethinylestradiol and 75 μg gestodene
  Contraception, 1988
• Serum levels of 3-keto-desogestrel and SHBG during 12 cycles of treatment with 30 μg ethinylestradiol and 150 μg desogestrel
  Contraception, 1988
• A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic parameters: I. Effects upon sexual hormone levels
  Contraception, 1985
• Effect of Oral Contraceptives on Plasma Androgenic Steroids and Their Precursors
  Obstetrics & Gynecology, 1978